Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity.
Overview
abstract
-
[This corrects the article .].
publication date
published in
Identity
PubMed Central ID
Scopus Document Identifier
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
volume